MBL protein (Bridge BioResearch)

N/A

Report date: 2022/03/09 10:53:57

Base Information

Drug NameMBL protein (Bridge BioResearch)
Drug Alias NameMBL protein (type 2 diabetes)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInsulin sensitizersPeroxisome proliferator activated receptor agonists
TargetsPeroxisome proliferator activated receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBridge Bioresearch Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBridge Bioresearch Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A